Financial Report & Highlights 2025
Analysis of developments during the year
In 2025, income of EBMT decreased compared to previous years. EBMT’s major sources of income are the Annual Meeting and revenue generated through post-authorisation safety (PAS) studies and pharmaceutical industry-initiated and/or partnered projects. Other sources of income are corporate sponsorships, certification fees, grants and investment income. In particular income through studies was less than previous years and even though income through other activities increased, direct costs related to some of these activities also increased.
Transformation and Consolidation Project
In anticipation of the projected reduction in income related to studies and pharma sponsorships, and in order to reinforce EBMT’s long term financial resilience, the Transformation and Consolidation Project was introduced. The focus of this project is to enhance efficiency and reduce costs across the organisation. It led to the introduction of new policies, while others are being developed and expected to be implemented in 2026.
The Registry
The replacement of the IT infrastructure of the Registry has been a key priority in recent years. The new Registry was developed under the oversight of the Clinical Research and Registry Department and the Registry Committee, and was launched in August 2023. The Registry was further developed in the following years, with a number of new releases. In 2025, MicroStrategy, the software aimed at enabling data access for the users of the EBMT Registry, was migrated to allow better access and performance for users. In October of the same year, the EBMT Registry achieved ISO/IEC 27001:2022 certification, demonstrating EBMT’s commitment to international standards for data security and processing. Development and implementation costs of the Registry were funded through the EuroTraCTOR grant and earmarked reserves. Investments in the Registry will continue in 2026.
Other IT: all in one cloud
Historically, EBMT offices had separate IT systems, hosted by the hospitals where EBMT held office. To create an efficient and sustainable IT infrastructure that supports the organizational structure and maximizes working efficiency, EBMT’s IT infrastructure was transformed into a cloud-based organizational structure. In 2024, the Barcelona and Leiden EBMT offices migrated to the EBMT cloud, which also hosts the Registry. The Paris office was able to join the EBMT cloud after it had moved to a new office in December 2025.
Working Parties
EBMT allocates an annual budget of 1.7M to support the activities of the Working Parties (WP). The distribution of these funds is based partly on performance criteria and partly on an equal-share allocation model. Performance criteria included publication impact factors, the number of abstracts presented at international meetings, the number of educational events organised, and the number of patients enrolled in the Registry. In 2024, a WP Budget Task Force was established to conduct a comprehensive evaluation of the WP budgeting framework. Its mandate was to redefine the distribution model in order to stimulate new scientific and educational activities and to better ensure a fairer allocation of resources. Following this review, it was decided that a larger portion—namely half of the budget for the working parties—would be allocated according to the equal-share model, with the remaining half distributed based on performance indicators. Weighing of these indicators was also revised, to reduce the emphasis on journal impact factors and place greater importance on educational activities.
Travel grants
Access to education is important, and EBMT’s Travel Grants Programme seeks to enable participants from diverse backgrounds to take part in EBMT events. In 2025 we have revised and updated the Travel Grant Program. The grants help reduce the financial barriers associated with attending events in person by covering registration fees as well as contributing to travel and accommodation costs. Coverage is according to region of origin: local, national, European, or international. In addition, we offer outreach grants for residents of countries defined by The World Bank Group as low-income economies or as lower-middle-income economies. Each year, approximately €110.000 is made available for these grants.
JACIE
The JACIE Certification process ensures rigorous quality standards for clinical and laboratory practice across Europe and internationally. In 2025, JACIE achieved a record milestone, conducting the highest number of inspections since JACIE was established in 1998.
Work force
To allow all educational, accreditation and scientific activities to grow, and to increase the efficiency of EBMT and its output in all fields, structural investments in the workforce have been made that resulted in a near doubling of FTE (and salary costs) between 2019 and 2024. With this, we have reached a point where all positions appear to be filled, and we do not anticipate the need for additional roles in the near future. To prevent further increases in salary expenses, we decided in 2025 not to refill vacated positions. As a result, salary costs have stabilized.
Concluding remarks
In 2025 we have experienced a decrease in income through studies, and even though income through other sources increased, EBMT has closed the year with a negative result. To reinforce EBMTs financial resilience, we will continue with the implementation of the Transformation and Consolidation Project in 2026. Importantly, 18% of EBMT income is spent on governance; 82% of resources is spent on the mission goals of the Society. For reference, overhead ratios of nonprofit organisations are typically around 20%. At the writing of this Annual Report, we are awaiting the report of the independent auditor. We trust that for 2025, as in the years before, EBMT will receive an ‘unqualified opinion’, indicating that the organisation’s financial statements qualify conform generally accepted accounting principles and fairly represent the organisation's financial position. I would like to express my appreciation to EBMT’s Finance Team for their excellent work and commitment.
Financial Highlights 2025
SOURCE OF INCOME | EUR | % | DESTINATION OF RESOURCES | EUR | % |
|---|---|---|---|---|---|
| EBMT MEMBERS DONATIONS | €238,000 | 1.3% | SCIENTIFIC STUDIES | €6,380,000 | 34.1% |
| SCIENTIFIC SPONSORS DONATIONS | €448,000 | 2.5% | EBMT REGISTRY | €1,917,000 | 10.2% |
| ANNUAL MEETING | €6,828,000 | 37.8% | ANNUAL MEETING | €3,048,000 | 16.2% |
| RESULTS FROM INVESTMENTS | €431,000 | 2.4% | EDUCATIONAL ACTIVITIES | €2,604,000 | 13.9% |
| STANDARDS & CERTIFICATION (JACIE) | €1,514,000 | 8.1% | |||
| NON-EARMARKED INCOME | €7,945,000 | 44.0% | TOTAL MISSION COST | €15,463,000 | 82.3% |
| GRANTS FOR STUDIES, CLINICAL TRIALS & EDUCATION | €8,484,000 | 46.9% | MANAGEMENT AND ADMINISTRATION | €3,319,000 | 17.7% |
| CERTIFICATION (JACIE) | €1,644,000 | 9.1% | |||
| EARMARKED INCOME | €10,128,000 | 56.0% | |||
| TOTAL INCOME | €18,073,000 | 100.0% | TOTAL EXPENDITURE | €18,782,000 | 100.0% |
FINANCIAL OUTCOME | EUR | % |
|---|---|---|
| TOTAL INCOME | €18,073,000 | 100.0% |
| TOTAL COSTS | €18,782,000 | 103.9% |
| GROSS RESULTS | - €709,000 | - 3.9% |
| EARMARKED | - €585,000 | - 3.2% |
| NET RESULT | - €124,000 | - 0.7% |
At the time of the report release date (March 22, 2026), the audit process is pending completion